VBI Vaccines is headquartered in Cambridge, Massachusetts.
VBI Vaccines disclosed revenue of 3M USD for 2014 and 2M USD for 2013.
VBI Vaccines has 127 employees.
VBI Vaccines is a life science company.
VBI Vaccines was founded in 2005.
222 Third Street Suite 2241,
Cambridge, Massachusetts
02142
United States,
(617) 830-3031
www.vbivaccines.com
VBI Vaccines is a biopharmaceutical company focused on the development and commercialization of novel and improved therapies for the prevention and treatment of hepatitis B and Graft-vs-Host Disease (GVHD) using our proprietary recombinant protein expertise. VBI Vaccines was founded in 2005 and is based in Cambridge, Massachusetts.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Legal | Deals |
|---|---|
|
GreenbergTraurig |
1 |
|
Blake, Cassels & Graydon |
1 |
|
Pearl Cohen |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
